Keratinocyte Growth Factor Receptors

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 477-485

  de Giorgi, Vincenzo ^a   Sestini, Serena ^a   Massi, Daniela ^a   Ghersetich, Ilaria ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; KERATINOCYTES; LIGANDS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION;

EID: 34548839091     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.017     Document Type: Review

References (45)

1. Capone A., Visco V., Belleudi F., et al. Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ 11 (2000) 607-614
2. Dlugosz A.A., Cheng C., Denning M.F., et al. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes. Cell Growth Differ 5 (1994) 1283-1292
3. Belleudi F., Ceridono M., Capone A., et al. The endocytic pathway followed by the keratinocyte growth factor receptor. Histochem Cell Biol 118 (2002) 1-10
4. Ostrovsky O., Berman B., Gallagher J., et al. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem 277 (2002) 2444-2453
5. Nagy N., Bata-Csorgo Z., Kopasz N., et al. The expression of keratinocyte growth factor receptor (FGFR2-IIIb) correlates with the high proliferative rate of HaCaT keratinocytes. Exp Dermatol 15 (2006) 596-605
6. Baraniak A.P., Chen J.R., and Garcia-Blanco M.A. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol Cell Biol 26 (2006) 1209-1222
7. Visco V., Belleudi F., Marchese C., et al. Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells. J Cell Physiol 200 (2004) 31-44
8. Marchese C., Maresca V., Cardinali G., et al. UVB-induced activation and internalization of keratinocyte growth factor receptor. Oncogene 22 (2003) 2422-2431
9. Ceridono M., Belleudi F., Ceccarelli S., et al. Tyrosine 769 of the keratinocyte growth factor receptor is required for receptor signaling but not endocytosis. Biochem Biophys Res Commun 327 (2005) 523-532
10. Belleudi F., Leone L., Aimati L., et al. Endocytic pathways and biological effects induced by UVB-dependent or ligand-dependent activation of the keratinocyte growth factor receptor. FASEB J 20 (2006) 395-397
11. Belleudi F., Visco V., Ceridono M., et al. Ligand-induced clathrin-mediated endocytosis of the keratinocyte growth factor receptor occurs independently of either phosphorylation or recruitment of eps 15. FEBS Lett 553 (2003) 262-270
12. Marchese C., Felici A., Visco V., et al. Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J Invest Dermatol 116 (2001) 623-628
13. Petiot A., Conti F.J.A., Grose R., et al. A crucial role of Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. Development 130 (2003) 5493-5501
14. Finch P.W., Murphy F., Cardinale I., et al. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathos 151 (1997) 1619-1628
15. Finch P.W., and Rubin J.S. Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst 98 (2006) 812-824
16. Nakamura T., Mochizuki Y., Kanetake H., et al. Signals via FGF receptor 2 regulate migration of endothelial cells. Biochem Biophys Res Commun 289 (2001) 801-806
17. Ramsay Camp E., Summy J., Bauer T.W., et al. Molecular mechanism of resistance to therapies targeting the epidermal growth factor receptor. Clin Cancer Res 11 (2005) 397-405
18. Yarden Y., and Sliwkowski M.X. Untangling the erbB signalling network. Nat Rev Mol Cell Biol 2 (2001) 127-137
19. Jorissen R.N., Walker F., Pouliot N., et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284 (2003) 31-53
20. Herbst R.S., and Shin D.M. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer 94 (2002) 1593-1611
21. Wujcik D. EGFR as a target: rationale for therapy. Semin Oncol Nurs 22 (2006) 5-9
22. Nunes M., Shi C., and Greenberger L.M. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes. Mol Cancer Ther 3 (2004) 21-27
23. Özcan F., Klein P., Lemmon M.A., et al. On the nature of low- and high-affinity EGF receptors on living cells. PNAS 103 (2006) 5735-5740
24. Garrett T., McKerm N., Lou M., et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 110 (2002) 763-773
25. Ogiso H., Ishitani R., Nureki O., et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110 (2002) 775-787
26. Yu X., Sharma K.D., Takahashi T., et al. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol Biol Cell 13 (2002) 2547-2557
27. Moriki T., Maruyama H., and Maruyama I.N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol 311 (2001) 1011-1026
28. Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal 13 (2001) 777-785
29. Pouyssegur J., Volmat V., and Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem Pharmacol 64 (2002) 755-763
30. Kloth M.T., Laughlin K.K., Biscardi J.S., et al. STAT 5b, a mediator of synergism between C-Src and the EGF receptor. J Biol Chem 278 (2003) 1671-1679
31. Leonard W.J. Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol 73 (2001) 271-277
32. Xia L., Wang L., Chung A.S., et al. Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation. J Biol Chem 277 (2002) 30716-30723
33. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
34. Djordjevic S., and Driscoll P.C. Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases. Trends Biochem Sci 27 (2002) 426-432
35. Nicholson K.M., and Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14 (2002) 381-395
36. Ferby I., Reschke M., Kudlacek O., et al. Mig 6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med 12 (2006) 568-573
37. El-Abaseri T.B., Putta S., and Hansen L.A. Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis 27 (2006) 225-231
38. Calautti E., Li J., Saoncella S., et al. Phosphoinositide 3-kinase signalling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 280 (2005) 32856-32865
39. Kassis J., Lauffenburger D.A., Turner T., et al. Tumor invasion as dysregulated cell motility. Semin Cancer Biol 11 (2001) 105-117
40. Glading A., Lauffenburger D.A., and Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 12 (2002) 46-54
41. Piccolo E., Innominato P.F., Mariggio M.A., et al. The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration. Oncogene 21 (2002) 6520-6529
42. Weiner O.D. Rac activation: P-Rex1- a convergence point for PIP(3) and Gbetagamma?. Curr Biol 12 (2002) R429-R431
43. Zhao M., Pu J., Forrester J.V., et al. Membrane lipids, EGF receptors, and intracellular signals colocalize and are polarized in epithelial cells moving directionally in a physiological electric field. FASEB J 16 (2002) 857-859
44. Jiang B.H., Zheng J.Z., Aoki M., et al. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 97 (2000) 1749-1753
45. Casanova M.L., Larcher F., Casanova B., et al. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res 62 (2002) 3402-3407